Anbio Biotechnology Class A Ordinary Shares Cash Flow Reinvestment Rate
Anbio Biotechnology Class A Ordinary Shares cash flow reinvestment rate. Anbio Biotechnology Class A Ordinary Shares (NNNN) has a Cash Flow Reinvestment Rate of 0.00x as of December 2024, reinvesting $1.67 (capex $1.67 ) from operating cash flow of $1.60 Million. Explore Anbio Biotechnology Class A Ordinary Sha debt service capacity to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Anbio Biotechnology Class A Ordinary Shares (2021–2024)
Cash flow reinvestment rate of Anbio Biotechnology Class A Ordinary Shares from 2021 to 2024. Historical reinvestment intensity for Anbio Biotechnology Class A Ordinary Shares across 4 annual periods. Explore NNNN capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Anbio Biotechnology Class A Ordinary Shares Cash Flow Reinvestment Rate by Year (2021–2024)
Anbio Biotechnology Class A Ordinary Shares cash flow reinvestment rate by year from 2021 to 2024. Year-by-year capital reinvestment analysis for Anbio Biotechnology Class A Ordinary Shares. For the full cash flow conversion analysis, see Anbio Biotechnology Class A Ordinary Sha (NNNN) cash flow conversion.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.16x | $337.10K | $2.08 Million | $0.00 | ▼ -91.6% |
| 2023 | 1.93x | $1.73 Million | $898.37K | $0.00 | ▲ +460.8% |
| 2022 | 0.34x | $1.53 Million | $4.45 Million | $2.88 | — |
| 2021 | 0.00x | $0.00 | $4.18 Million | $0.00 | — |